Development

Ramesh Kumar is a graduate student at the Indian Institute of Technology, Delhi.

Manidipa Banerjee is a professor in the Kusuma School of Biological Sciences at the Indian Institute of Technology, Delhi.

Anurag S. Rathore is a professor in the Department of Chemical Engineering at the Indian Institute of Technology Delhi and a member of 

l's Editorial Advisory Board, Tel. +91.9650770650, asrathore@biotechcmz.com.

Articles

Analytical and functional characterization of virus-like particles enables process reproducibility and product consistency. 

Virus-like Particles as Therapeutic Moieties of the Future

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA. 

Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center 

Feliza Mirasol is the science editor for 

Bio/Pharma companies are galvanized to develop COVID-19 therapies under FDA’s acceleration program.

Bio/Pharma Industry Works Overtime to Find COVID-19 Therapies

Narendra Chirmule, PhD, is CEO at SymphonyTech Biologics.

Himanshu Malani is a graduate student at the Indian Institute of Technology, Delhi.

Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.

Reimagining Affordable Biosimilars

Preliminary data from a German Phase I/II trial shows Pfizer/BioNTech COVID-19 vaccine candidate produces immune response.

mRNA Vaccine Produces Immune and T-cell Response

Strong immune response by patients receiving two doses of vaccine suggests a possible treatment strategy.

AstraZeneca Vaccine Shows Antibody and T-cell responses

SGS has announced the receipt of approval from Belgium’s Federal Agency for Medicines and Health Products (FAMHP) to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.

SGS Initiates Clinical Trial of Biophytis’ Treatment for COVID-19 Related Respiratory Failure

GlaxoSmithKline (GSK) and Medicago have announced a collaboration for the development and evaluation of a COVID-19 vaccine candidate. 

GSK, Medicago Collaborate on Covid-19 Vaccine Candidate

The European Directorate for the Quality of Medicines and Healthcare (EDQM) has published a new general chapter (2.6.32) in the European Pharmacopoeia (Ph. Eur.) supplement 10.3.

EDQM Publishes New General Chapter in European Pharmacopoeia Supplement 10.3

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Early Phase Development